Connect Biopharma Holdings (Connect Biopharma Holdings) Price-to-Tangible-Book : 0.73 (As of Apr. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Price-to-Tangible-Book?

As of today (2024-04-25), Connect Biopharma Holdings's share price is $1.34. Connect Biopharma Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.83. Hence, Connect Biopharma Holdings's Price to Tangible Book Ratio of today is 0.73.

The historical rank and industry rank for Connect Biopharma Holdings's Price-to-Tangible-Book or its related term are showing as below:

CNTB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.31 Med: 0.64 Max: 1.06
Current: 0.73

During the past 5 years, Connect Biopharma Holdings's highest Price to Tangible Book Ratio was 1.06. The lowest was 0.31. And the median was 0.64.

CNTB's Price-to-Tangible-Book is ranked better than
87.7% of 1220 companies
in the Biotechnology industry
Industry Median: 2.67 vs CNTB: 0.73

A closely related ratio is called PB Ratio. As of today, Connect Biopharma Holdings's share price is $1.34. Connect Biopharma Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.83. Hence, Connect Biopharma Holdings's P/B Ratio of today is 0.73.

Connect Biopharma Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Connect Biopharma Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Price-to-Tangible-Book Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

1.06

0.31

0.64

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial				1.06	0.23	0.31	0.49	0.64

Competitive Comparison of Connect Biopharma Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Connect Biopharma Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Connect Biopharma Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's Price-to-Tangible-Book falls into.

Connect Biopharma Holdings Price-to-Tangible-Book Calculation

Connect Biopharma Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.34	/	1.833
	=	0.73

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Connect Biopharma Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.